Pricing
EyeCyte
Contact
No bio yet
James Dykens
CEO
This person is not in any teams
This person is not in any offices
EyeCyte is engaged in the development of therapeutics for the treatment of neovascular and degenerative retinal diseases.
Industries
Headquarters
Employees
Links
Mach Industries
ISX Financial
CIS
Stan
FIRMUS
View more